Screener
Cullinan Therapeutics, Inc. CGEM Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210304
FAQ
- What is Cullinan Therapeutics, Inc.'s net change in cash?
- Cullinan Therapeutics, Inc. (CGEM) reported net change in cash of -$13.25M in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s net change in cash changed year-over-year?
- Cullinan Therapeutics, Inc.'s net change in cash decreased by 108.7% year-over-year, from -$6.35M to -$13.25M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Cullinan Therapeutics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude